Utility of the Treatment-Related Mortality (TRM) score to predict outcomes of adults with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation
Lucas C. Zarling, Megan Othus, Brenda M. Sandmaier, Filippo Milano, Gary Schoch, Chris Davis, Marie Bleakley, H. Joachim Deeg, Frederick R. Appelbaum, Rainer Storb, Roland B. Walter
Topics & Concepts
MedicineInternal medicineQuartileTransplantationConfidence intervalFramingham Risk ScoreHematopoietic cellHematopoietic stem cell transplantationOncologyHaematopoiesisDiseaseStem cellBiologyGeneticsAcute Myeloid Leukemia ResearchHematopoietic Stem Cell TransplantationAcute Lymphoblastic Leukemia research